ES2925365T3 - Método para producir derivados de diarilpiridina - Google Patents
Método para producir derivados de diarilpiridina Download PDFInfo
- Publication number
- ES2925365T3 ES2925365T3 ES19831009T ES19831009T ES2925365T3 ES 2925365 T3 ES2925365 T3 ES 2925365T3 ES 19831009 T ES19831009 T ES 19831009T ES 19831009 T ES19831009 T ES 19831009T ES 2925365 T3 ES2925365 T3 ES 2925365T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- contents
- added
- compound represented
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018127197 | 2018-07-04 | ||
| PCT/JP2019/026395 WO2020009132A1 (ja) | 2018-07-04 | 2019-07-03 | ジアリールピリジン誘導体の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2925365T3 true ES2925365T3 (es) | 2022-10-17 |
Family
ID=69059540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES19831009T Active ES2925365T3 (es) | 2018-07-04 | 2019-07-03 | Método para producir derivados de diarilpiridina |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11999724B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3819296B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7337058B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112368271A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019299152A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3105328A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2925365T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL279070B2 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI840378B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020009132A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2023090337A1 (cg-RX-API-DMAC7.html) | 2021-11-19 | 2023-05-25 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201404505PA (en) * | 2012-01-31 | 2014-10-30 | Daiichi Sankyo Co Ltd | Pyridone derivative |
| TWI723572B (zh) * | 2014-07-07 | 2021-04-01 | 日商第一三共股份有限公司 | 具有四氫吡喃基甲基之吡啶酮衍生物及其用途 |
| TWI796326B (zh) | 2017-03-24 | 2023-03-21 | 日商第一三共股份有限公司 | 含有ａｘｌ抑制劑與ｅｇｆｒ酪胺酸激酶抑制藥的醫藥品及其用途 |
-
2019
- 2019-07-01 TW TW108123125A patent/TWI840378B/zh not_active IP Right Cessation
- 2019-07-03 JP JP2020529019A patent/JP7337058B2/ja active Active
- 2019-07-03 WO PCT/JP2019/026395 patent/WO2020009132A1/ja not_active Ceased
- 2019-07-03 AU AU2019299152A patent/AU2019299152A1/en not_active Abandoned
- 2019-07-03 EP EP19831009.6A patent/EP3819296B1/en active Active
- 2019-07-03 US US17/252,469 patent/US11999724B2/en active Active
- 2019-07-03 CA CA3105328A patent/CA3105328A1/en active Pending
- 2019-07-03 ES ES19831009T patent/ES2925365T3/es active Active
- 2019-07-03 CN CN201980043226.0A patent/CN112368271A/zh active Pending
- 2019-07-03 IL IL279070A patent/IL279070B2/en unknown
-
2023
- 2023-08-22 JP JP2023134392A patent/JP2023159297A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202005962A (zh) | 2020-02-01 |
| US20210188823A1 (en) | 2021-06-24 |
| JP2023159297A (ja) | 2023-10-31 |
| CA3105328A1 (en) | 2020-01-09 |
| IL279070B2 (en) | 2024-05-01 |
| JPWO2020009132A1 (ja) | 2021-07-08 |
| CN112368271A (zh) | 2021-02-12 |
| WO2020009132A1 (ja) | 2020-01-09 |
| EP3819296B1 (en) | 2022-06-29 |
| AU2019299152A1 (en) | 2021-03-04 |
| US11999724B2 (en) | 2024-06-04 |
| AU2019299152A2 (en) | 2021-03-11 |
| IL279070A (en) | 2021-01-31 |
| TWI840378B (zh) | 2024-05-01 |
| IL279070B1 (en) | 2024-01-01 |
| EP3819296A4 (en) | 2021-06-09 |
| EP3819296A1 (en) | 2021-05-12 |
| JP7337058B2 (ja) | 2023-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026500533A (ja) | Ｋｒａｓ ｇ１２ｄ阻害剤の結晶形及び調製方法 | |
| CN109153687B (zh) | 一类含有三环杂芳基的化合物 | |
| US11629153B2 (en) | Forms and compositions of a MK2 inhibitor | |
| CN112300153B (zh) | 一种杂环化合物、药物组合物和用途 | |
| BR112015017963A2 (pt) | composto de fenil amino pirimidina deuterado, método para preparar a composição farmacêutica, composição farmacêutica e uso do composto | |
| KR20160073413A (ko) | 퀴나졸리논 및 이소퀴놀리논 유도체 | |
| ES2451140T3 (es) | Cristal de derivado de fenilalanina y método para su producción | |
| CA3160478A1 (en) | Wdr5 inhibitors and modulators | |
| JP2023134749A (ja) | マクロライド誘導体、その製造方法および用途 | |
| CN120917029A (zh) | 结晶形式 | |
| ES2974328T3 (es) | Formas sólidas de 3-(5-fluorobenzofuran-3-il)-4-(5-metil-5h[1,3]dioxolo[4,5-f]indol-7-il)pirrol-2,5-diona | |
| KR20180033514A (ko) | Fgfr 억제제를 제조하기 위한 방법 | |
| JP2023159297A (ja) | ジアリールピリジン誘導体の製造方法 | |
| KR102891811B1 (ko) | 3-(5-플루오로벤조푸란-3-일)-4-(5-메틸-5H-[1,3]디옥솔로[4,5-f]인돌-7-일)피롤-2,5-디온의 고체 형태 | |
| JP2020193209A (ja) | チアゾール誘導体の製造方法 | |
| JP6165335B2 (ja) | ゲフィチニブの新規な結晶形およびその製造方法 | |
| AU2019218150B2 (en) | Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor | |
| KR20240089380A (ko) | 마보릭사포의 합성 및 그 중간체 | |
| BR122025016219A2 (pt) | Formas de sal de um composto inibidor de cyp11a1 estruturado com 4h-piran-4-ona, métodos para preparar as mesmas, composição farmacêutica e uso das referidas formas de sal para o tratamento de cânceres hormonalmente regulados | |
| CN122036704A (zh) | 一种联芳基化合物的游离碱晶型或酸式盐、其制备方法和医药用途 | |
| BR112020007538B1 (pt) | Forma sólida, processo para preparar a forma sólida, composição farmacêutica, processo para preparar a composição farmacêutica e uso da forma sólida | |
| BR122025019554A2 (pt) | Forma sólida de 3-(5-flúor-benzofuran-3-il)-4-(5-metil-5h-[1,3]dioxolo[4,5- f]indol-7-il)pirrol-2,5-diona, seus usos, composição farmacêutica e processo para preparar a mesma |